Delivery Order SPE2DB24D9238-SPE2DB25FDQLB
Award Date
1/17/25
Potential Completion Date
2/10/25
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,424.46 firm fixed-price delivery order is for Xolair 300 mg/2 ml syringes to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a comprehensive range of pharmaceutical items and is valued at up to $499,999,999. DMS Pharmaceutical...
This is a firm fixed-price delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $9,284.40 contract is for the supply of Xolair 150 mg/mL syringes, a specialty biologic medication. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,321.10 contract is for the supply of Xolair 150 mg/mL syringes. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,094.80, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,605.50 firm fixed-price contract is for the delivery of Xolair 150 mg/ml syringes, a specialized medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $6,963.30 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Xolair 150 mg/mL syringes. This delivery order was placed under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to order a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the supply of XOLAIR 150 MG/ML syringes. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,737 contract is for the delivery of Xolair 150 mg/ml syringes, a specialized pharmaceutical product, with a period of performance through February 27, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a $22,606.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,566,263 units of the pharmaceutical product Xolair 300 mg/2 ml syringe. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The contract covers a comprehensive range of pharmaceutical products,...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB24 contract. The $23,211 firm fixed-price order is for the supply of Xolair 150 mg/mL syringes, a specialty medication. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, allowing the agency to issue delivery orders for a wide range of...